Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
46
JNDOF Quote, Financials, Valuation and Earnings
Last price:
$22.75
Seasonality move
:
3.31%
Day range:
$22.75 - $22.75
52-week range:
$22.75 - $22.75
Dividend yield:
3.11%
P/E ratio:
9.35x
P/S ratio:
0.79x
P/B ratio:
2.61x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$531M
Revenue:
$653.4M
EPS (TTM):
$2.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JNDOF
Jins Holdings, Inc.
|
$166.4M | -- | 5.04% | -- | -- |
|
AMGXF
AnGes, Inc.
|
-- | -- | -- | -- | -- |
|
HLOSF
Healios KK
|
-- | -- | -- | -- | -- |
|
PPTDF
PeptiDream Inc.
|
-- | -- | -- | -- | -- |
|
SOLTF
Nxera Pharma Co., Ltd.
|
-- | -- | -- | -- | -- |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JNDOF
Jins Holdings, Inc.
|
$22.75 | -- | $531M | 9.35x | $0.31 | 3.11% | 0.79x |
|
AMGXF
AnGes, Inc.
|
$0.36 | -- | $142.5M | -- | $0.00 | 0% | 21.89x |
|
HLOSF
Healios KK
|
$2.20 | -- | $297M | -- | $0.00 | 0% | 343.65x |
|
PPTDF
PeptiDream Inc.
|
$8.18 | -- | $1.1B | 13.79x | $0.00 | 0% | 8.56x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$5.28 | -- | $477.8M | -- | $0.00 | 0% | 2.40x |
|
STMM
Stemcell Holdings, Inc.
|
$0.06 | -- | $60M | -- | $0.00 | 0% | 0.17x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JNDOF
Jins Holdings, Inc.
|
14.04% | -0.019 | 6.27% | 0.77x |
|
AMGXF
AnGes, Inc.
|
1.74% | 0.000 | 0.25% | 0.89x |
|
HLOSF
Healios KK
|
34.82% | 2.114 | 7.46% | 1.83x |
|
PPTDF
PeptiDream Inc.
|
27.41% | 1.316 | 7.7% | 1.47x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
48.47% | 0.726 | 73.82% | 1.51x |
|
STMM
Stemcell Holdings, Inc.
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JNDOF
Jins Holdings, Inc.
|
$126.2M | $13.4M | 23.1% | 28.9% | 8.44% | -- |
|
AMGXF
AnGes, Inc.
|
$399.5K | -$10.4M | -153.93% | -162.7% | -703% | -- |
|
HLOSF
Healios KK
|
-$798.3K | -$6.6M | -44.36% | -88.96% | -4043.07% | -$5.3M |
|
PPTDF
PeptiDream Inc.
|
$17.4M | -$6M | -5.2% | -7.06% | -16.33% | -$2.8M |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$37.1M | -$8.9M | -9.66% | -19.06% | -17.59% | -$1M |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- | -- |
Jins Holdings, Inc. vs. Competitors
-
Which has Higher Returns JNDOF or AMGXF?
AnGes, Inc. has a net margin of 6.1% compared to Jins Holdings, Inc.'s net margin of -190.55%. Jins Holdings, Inc.'s return on equity of 28.9% beat AnGes, Inc.'s return on equity of -162.7%.
Company Gross Margin Earnings Per Share Invested Capital JNDOFJins Holdings, Inc.79.57% $0.41 $237.1M AMGXFAnGes, Inc.27% -$0.01 $20M -
What do Analysts Say About JNDOF or AMGXF?
Jins Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand AnGes, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jins Holdings, Inc. has higher upside potential than AnGes, Inc., analysts believe Jins Holdings, Inc. is more attractive than AnGes, Inc..
Company Buy Ratings Hold Ratings Sell Ratings JNDOFJins Holdings, Inc.0 0 0 AMGXFAnGes, Inc.0 0 0 -
Is JNDOF or AMGXF More Risky?
Jins Holdings, Inc. has a beta of -0.467, which suggesting that the stock is 146.661% less volatile than S&P 500. In comparison AnGes, Inc. has a beta of 0.039, suggesting its less volatile than the S&P 500 by 96.075%.
-
Which is a Better Dividend Stock JNDOF or AMGXF?
Jins Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 3.11%. AnGes, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jins Holdings, Inc. pays 30.54% of its earnings as a dividend. AnGes, Inc. pays out -- of its earnings as a dividend. Jins Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios JNDOF or AMGXF?
Jins Holdings, Inc. quarterly revenues are $158.6M, which are larger than AnGes, Inc. quarterly revenues of $1.5M. Jins Holdings, Inc.'s net income of $9.7M is higher than AnGes, Inc.'s net income of -$2.8M. Notably, Jins Holdings, Inc.'s price-to-earnings ratio is 9.35x while AnGes, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jins Holdings, Inc. is 0.79x versus 21.89x for AnGes, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JNDOFJins Holdings, Inc.0.79x 9.35x $158.6M $9.7M AMGXFAnGes, Inc.21.89x -- $1.5M -$2.8M
-
Which has Higher Returns JNDOF or HLOSF?
Healios KK has a net margin of 6.1% compared to Jins Holdings, Inc.'s net margin of -9751.87%. Jins Holdings, Inc.'s return on equity of 28.9% beat Healios KK's return on equity of -88.96%.
Company Gross Margin Earnings Per Share Invested Capital JNDOFJins Holdings, Inc.79.57% $0.41 $237.1M HLOSFHealios KK-491.87% $0.11 $47.9M -
What do Analysts Say About JNDOF or HLOSF?
Jins Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healios KK has an analysts' consensus of -- which suggests that it could fall by --. Given that Jins Holdings, Inc. has higher upside potential than Healios KK, analysts believe Jins Holdings, Inc. is more attractive than Healios KK.
Company Buy Ratings Hold Ratings Sell Ratings JNDOFJins Holdings, Inc.0 0 0 HLOSFHealios KK0 0 0 -
Is JNDOF or HLOSF More Risky?
Jins Holdings, Inc. has a beta of -0.467, which suggesting that the stock is 146.661% less volatile than S&P 500. In comparison Healios KK has a beta of 0.237, suggesting its less volatile than the S&P 500 by 76.316%.
-
Which is a Better Dividend Stock JNDOF or HLOSF?
Jins Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 3.11%. Healios KK offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jins Holdings, Inc. pays 30.54% of its earnings as a dividend. Healios KK pays out -- of its earnings as a dividend. Jins Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios JNDOF or HLOSF?
Jins Holdings, Inc. quarterly revenues are $158.6M, which are larger than Healios KK quarterly revenues of $162.3K. Jins Holdings, Inc.'s net income of $9.7M is lower than Healios KK's net income of $12.4M. Notably, Jins Holdings, Inc.'s price-to-earnings ratio is 9.35x while Healios KK's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jins Holdings, Inc. is 0.79x versus 343.65x for Healios KK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JNDOFJins Holdings, Inc.0.79x 9.35x $158.6M $9.7M HLOSFHealios KK343.65x -- $162.3K $12.4M
-
Which has Higher Returns JNDOF or PPTDF?
PeptiDream Inc. has a net margin of 6.1% compared to Jins Holdings, Inc.'s net margin of -9.39%. Jins Holdings, Inc.'s return on equity of 28.9% beat PeptiDream Inc.'s return on equity of -7.06%.
Company Gross Margin Earnings Per Share Invested Capital JNDOFJins Holdings, Inc.79.57% $0.41 $237.1M PPTDFPeptiDream Inc.47.44% -$0.03 $452.8M -
What do Analysts Say About JNDOF or PPTDF?
Jins Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand PeptiDream Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jins Holdings, Inc. has higher upside potential than PeptiDream Inc., analysts believe Jins Holdings, Inc. is more attractive than PeptiDream Inc..
Company Buy Ratings Hold Ratings Sell Ratings JNDOFJins Holdings, Inc.0 0 0 PPTDFPeptiDream Inc.0 0 0 -
Is JNDOF or PPTDF More Risky?
Jins Holdings, Inc. has a beta of -0.467, which suggesting that the stock is 146.661% less volatile than S&P 500. In comparison PeptiDream Inc. has a beta of 0.672, suggesting its less volatile than the S&P 500 by 32.786%.
-
Which is a Better Dividend Stock JNDOF or PPTDF?
Jins Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 3.11%. PeptiDream Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jins Holdings, Inc. pays 30.54% of its earnings as a dividend. PeptiDream Inc. pays out -- of its earnings as a dividend. Jins Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios JNDOF or PPTDF?
Jins Holdings, Inc. quarterly revenues are $158.6M, which are larger than PeptiDream Inc. quarterly revenues of $36.8M. Jins Holdings, Inc.'s net income of $9.7M is higher than PeptiDream Inc.'s net income of -$3.5M. Notably, Jins Holdings, Inc.'s price-to-earnings ratio is 9.35x while PeptiDream Inc.'s PE ratio is 13.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jins Holdings, Inc. is 0.79x versus 8.56x for PeptiDream Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JNDOFJins Holdings, Inc.0.79x 9.35x $158.6M $9.7M PPTDFPeptiDream Inc.8.56x 13.79x $36.8M -$3.5M
-
Which has Higher Returns JNDOF or SOLTF?
Nxera Pharma Co., Ltd. has a net margin of 6.1% compared to Jins Holdings, Inc.'s net margin of -99.41%. Jins Holdings, Inc.'s return on equity of 28.9% beat Nxera Pharma Co., Ltd.'s return on equity of -19.06%.
Company Gross Margin Earnings Per Share Invested Capital JNDOFJins Holdings, Inc.79.57% $0.41 $237.1M SOLTFNxera Pharma Co., Ltd.73.58% -$0.55 $755.2M -
What do Analysts Say About JNDOF or SOLTF?
Jins Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Nxera Pharma Co., Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jins Holdings, Inc. has higher upside potential than Nxera Pharma Co., Ltd., analysts believe Jins Holdings, Inc. is more attractive than Nxera Pharma Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JNDOFJins Holdings, Inc.0 0 0 SOLTFNxera Pharma Co., Ltd.0 0 0 -
Is JNDOF or SOLTF More Risky?
Jins Holdings, Inc. has a beta of -0.467, which suggesting that the stock is 146.661% less volatile than S&P 500. In comparison Nxera Pharma Co., Ltd. has a beta of 0.021, suggesting its less volatile than the S&P 500 by 97.926%.
-
Which is a Better Dividend Stock JNDOF or SOLTF?
Jins Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 3.11%. Nxera Pharma Co., Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jins Holdings, Inc. pays 30.54% of its earnings as a dividend. Nxera Pharma Co., Ltd. pays out -- of its earnings as a dividend. Jins Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios JNDOF or SOLTF?
Jins Holdings, Inc. quarterly revenues are $158.6M, which are larger than Nxera Pharma Co., Ltd. quarterly revenues of $50.4M. Jins Holdings, Inc.'s net income of $9.7M is higher than Nxera Pharma Co., Ltd.'s net income of -$50.1M. Notably, Jins Holdings, Inc.'s price-to-earnings ratio is 9.35x while Nxera Pharma Co., Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jins Holdings, Inc. is 0.79x versus 2.40x for Nxera Pharma Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JNDOFJins Holdings, Inc.0.79x 9.35x $158.6M $9.7M SOLTFNxera Pharma Co., Ltd.2.40x -- $50.4M -$50.1M
-
Which has Higher Returns JNDOF or STMM?
Stemcell Holdings, Inc. has a net margin of 6.1% compared to Jins Holdings, Inc.'s net margin of --. Jins Holdings, Inc.'s return on equity of 28.9% beat Stemcell Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JNDOFJins Holdings, Inc.79.57% $0.41 $237.1M STMMStemcell Holdings, Inc.-- -- -- -
What do Analysts Say About JNDOF or STMM?
Jins Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stemcell Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jins Holdings, Inc. has higher upside potential than Stemcell Holdings, Inc., analysts believe Jins Holdings, Inc. is more attractive than Stemcell Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings JNDOFJins Holdings, Inc.0 0 0 STMMStemcell Holdings, Inc.0 0 0 -
Is JNDOF or STMM More Risky?
Jins Holdings, Inc. has a beta of -0.467, which suggesting that the stock is 146.661% less volatile than S&P 500. In comparison Stemcell Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JNDOF or STMM?
Jins Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 3.11%. Stemcell Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jins Holdings, Inc. pays 30.54% of its earnings as a dividend. Stemcell Holdings, Inc. pays out -- of its earnings as a dividend. Jins Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios JNDOF or STMM?
Jins Holdings, Inc. quarterly revenues are $158.6M, which are larger than Stemcell Holdings, Inc. quarterly revenues of --. Jins Holdings, Inc.'s net income of $9.7M is higher than Stemcell Holdings, Inc.'s net income of --. Notably, Jins Holdings, Inc.'s price-to-earnings ratio is 9.35x while Stemcell Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jins Holdings, Inc. is 0.79x versus 0.17x for Stemcell Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JNDOFJins Holdings, Inc.0.79x 9.35x $158.6M $9.7M STMMStemcell Holdings, Inc.0.17x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
